Noerr advised DiaSorin S.p.A. on the acquisition of a business portfolio from SIEMENS Healthineers
Noerr has accompanied Italian DiaSorin S.p.A. on the German-law aspects of the acquisition of the international micro-titre based ELISA immunodiagnostic business portfolio from Siemens Healthineers GmbH and affiliated companies (“SIEMENS Healthineers”). The publicly listed medical diagnostics specialist was advised by a team headed by Hamburg partners Björn Paulsen and Dr. Stephan Schulz.